Amantadine `value for money' for influenza in the UK

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1342, 2002-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amantadine `value for money' for influenza in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 367, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The UK NICE has released draft guidelines for the use of amantadine, oseltamivir and zanamivir for influenza prophylaxis.

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Influenza vaccination programme worth it in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Amantadine and oseltamivir in combination are more effective than either agent alone for H5N1 influenza virus infection

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Bevacizumab "best value for money" in MCRC . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite